Company Profile
Immutep Limited Stock Price, News & Analysis
- Ticker:
- IMMP
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Immutep Limited is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
0.39 USD (+4.43%)
Close
Last updated: June 23, 2026 at 00:00
58.05M USD
Market cap
Why the stock is moving
IMMP is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Immutep Limited is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Immutep Limited is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Immutep Limited follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Immutep Limited sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Immutep Limited (IMMP)?
Immutep Limited (IMMP) most recently closed at 0.39 USD, a +4.43% move versus the previous session.
What is the market cap of Immutep Limited (IMMP)?
Immutep Limited currently has a market capitalization of 58.05M USD on BioPharmSignal.
What does Immutep Limited do?
Immutep Limited is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is IMMP stock listed?
Immutep Limited (IMMP) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Immutep Limited is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Immutep?
Immutep Limited is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Immutep Limited targeting with Immutep?
Immutep Limited is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Limited?
Immutep Limited is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.